The burden of Cushing's disease: clinical and health-related quality of life aspects.
about
Systemic therapy of Cushing's syndromeComorbidities in Cushing's diseaseThe Treatment of Cushing's Disease.Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegalyCushing's disease: a multidisciplinary overview of the clinical features, diagnosis, and treatmentThe risks of overlooking the diagnosis of secreting pituitary adenomasSerotonergic systems in the balance: CRHR1 and CRHR2 differentially control stress-induced serotonin synthesis.Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.Case Report of Cushing's Syndrome with an Acute Psychotic Presentation.Long-term treatment of Cushing's disease with pasireotide: 5-year results from an open-label extension study of a Phase III trialExtended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study.Short-term, low-dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiencyDepression, smoking, physical inactivity and season independently associated with midnight salivary cortisol in type 1 diabetes.Both transient and continuous corticosterone excess inhibit atherosclerotic plaque formation in APOE*3-leiden.CETP miceThe hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea.Cushing's syndrome: epidemiology and developments in disease management.Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelinePasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trialGlucocorticoids and type 2 diabetes: from physiology to pathologyLong-term health-related quality of life of surgically treated pituitary adenoma patients: a descriptive study.Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome.Diagnosis and Multimodality Management of Cushing's Disease: A Practical Review.Algorithm development and the clinical and economic burden of Cushing's disease in a large US health plan databaseCases of Psychiatric Morbidity in Pediatric Patients After Remission of Cushing Syndrome.Quality of life and other outcomes in children treated for Cushing syndrome.Pigmented lesions of the oral cavity: an update.Monitoring Patient Improvement Parameters following Pasireotide Treatment in Cushing's Disease.Phenotype-Genotype Association Analysis of ACTH-Secreting Pituitary Adenoma and Its Molecular Link to Patient Osteoporosis.Metabolomic Biomarkers in Urine of Cushing's Syndrome Patients.Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas.Patterns of correlation of facial shape with physiological measurements are more integrated than patterns of correlation with ratings.Pasireotide: a review of its use in Cushing's disease.Recent developments in drug therapy for Cushing's disease.Efficacy of medical treatment in Cushing's disease: a systematic review.Managing Cushing's disease: the state of the art.Ectopic ACTH-secreting pituitary adenomas within the sphenoid sinus.Detection of recurrent Cushing's disease: proposal for standardized patient monitoring following transsphenoidal surgery.Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.Incremental healthcare resource utilization and costs in US patients with Cushing's disease compared with diabetes mellitus and population controls.
P2860
Q22000607-532A0A8C-D7B9-43CC-BE32-58FC0AED9E5DQ27010491-F5A8CA37-678E-4A48-AE5C-47F7CABBB87FQ27010590-6E71C115-37FC-49BB-A2DA-1C2E65EF5BB1Q28069603-17755F9A-07A0-4C49-B384-97CD5A007117Q28071635-F37EC222-2C18-4E60-84C4-D08AECDB3354Q28076665-9D2F4D77-CE65-4765-925B-1E6B1B6ABF49Q30367018-842C5704-E7C7-4DB8-9D6F-C3AB51C08F24Q33622368-CB81556F-BB07-4017-BFAB-37737A4C9185Q33695914-D7B33272-8F8A-4131-9401-ED7E218B4B65Q33840655-6568E8DA-B0A7-473E-A483-CF8614685444Q33858344-46EA7325-21DF-4D94-A0DC-DD587CEDDE01Q34284698-6FAE23A0-1754-4419-B7C5-D3123B5FBB87Q34538115-52ACEC59-2911-49E4-8F19-D20A639A350BQ34744777-F199E7E7-DEFE-4012-A834-530620CEF51DQ35126105-996E34B0-1AF8-4DBA-A400-16A2033A6113Q35260959-C2F78483-53F6-426A-9F99-E15360BBD613Q35531889-333EDDEC-E938-4C57-8B4D-0D87943A73B0Q35916555-241C2424-6706-440A-B6F3-26152B4BB3D1Q36030010-439F429C-66BD-499F-8AAA-E3021E0B0E69Q36506631-1C1549BB-B322-48CA-8D57-F885D5411546Q36546547-FA46B59A-CDEE-45AE-AE6F-9D1DD5ADA89EQ36547837-32F759F1-2B81-4647-B172-BB8A33BD10E7Q36582436-54829C4E-1A62-4654-AA42-646C241C7F63Q36704444-5056B2E8-67BD-49B4-9184-D362BC5A3689Q36738333-4CCCD362-0036-4140-8FFC-2DEE8F2C76C9Q36981968-82435A85-ADBD-4FFF-9F41-0BC99A3DB5C1Q37177510-B37FE1DB-5406-44CB-B8F0-5DC088478648Q37322951-60853F6A-883A-4985-A412-DEC15A9EEA08Q37377304-AFA03541-435D-4A82-A0B7-994032DBDC87Q37690743-8EBB158B-132F-4559-ABD4-EB495F29A633Q37714445-3B03D5C8-CD1D-461D-A61B-AC7CC0967EBCQ37723974-57008D9E-F541-49B8-AE40-0D761B148EFBQ38100715-67E0B445-58BB-4BE1-9C72-D2101797821FQ38112082-5548AB6F-B476-4A69-9610-9D92AEB1A4ABQ38151882-7969169A-EE4C-4C78-8E08-BCCA94D5C20FQ38177740-E99DEA6B-7EEB-42C0-BC03-9B82EDCD9794Q38220084-F6FDCFA4-BA1C-4F1F-A697-610F716EF096Q38224779-FFA5657A-2BC9-48DD-BF66-B99B37154A0EQ38307934-07CB1699-D546-4E50-AF73-F254753F0924Q38405559-15B4281F-3AC9-4B72-A3CE-9DA41F4D9349
P2860
The burden of Cushing's disease: clinical and health-related quality of life aspects.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The burden of Cushing's disease: clinical and health-related quality of life aspects.
@en
type
label
The burden of Cushing's disease: clinical and health-related quality of life aspects.
@en
prefLabel
The burden of Cushing's disease: clinical and health-related quality of life aspects.
@en
P2093
P356
P1476
The burden of Cushing's disease: clinical and health-related quality of life aspects.
@en
P2093
A M Pereira
R A Feelders
S J Pulgar
P304
P356
10.1530/EJE-11-1095
P577
2012-06-22T00:00:00Z